Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Chemours Company (NYSE: CC) closed at $16.82 down -1.12% from its previous closing price of $17.01. In other words, the price has decreased by -$1.12 from its previous closing price. On the day, 1.26 million shares were traded. CC stock price reached its highest trading level at $17.01 during the session, while it also had its lowest trading level at $16.47.
Ratios:
For a deeper understanding of Chemours Company’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.92 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 6.53 whereas as Long-Term Debt/Eq ratio is at 6.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on July 09, 2024, Upgraded its rating to Buy and sets its target price to $30 from $28 previously.
On June 07, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $25.
BMO Capital Markets Upgraded its Underperform to Outperform on April 09, 2024, whereas the target price for the stock was revised from $19 to $34.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when Scarborough Alvenia sold 7,500 shares for $20.64 per share. The transaction valued at 154,771 led to the insider holds 16,645 shares of the business.
Scarborough Alvenia bought 7,500 shares of CC for $150,000 on Nov 06 ’24. On Aug 07 ’24, another insider, Picho Diane I., who serves as the Interim Pres. – Titanium Tech of the company, sold 2,684 shares for $18.82 each. As a result, the insider received 50,519 and left with 19,890 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CC now has a Market Capitalization of 2513093120 and an Enterprise Value of 6209084928. As of this moment, Chemours’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.77, and their Forward P/E ratio for the next fiscal year is 7.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 3.82. Its current Enterprise Value per Revenue stands at 1.08 whereas that against EBITDA is 7.9.
Stock Price History:
Over the past 52 weeks, CC has reached a high of $32.70, while it has fallen to a 52-week low of $15.10. The 50-Day Moving Average of the stock is -13.43%, while the 200-Day Moving Average is calculated to be -24.61%.
Shares Statistics:
For the past three months, CC has traded an average of 1.67M shares per day and 1660730 over the past ten days. A total of 149.39M shares are outstanding, with a floating share count of 148.33M. Insiders hold about 0.72% of the company’s shares, while institutions hold 81.99% stake in the company. Shares short for CC as of 1734048000 were 7153005 with a Short Ratio of 4.28, compared to 1731628800 on 7282388. Therefore, it implies a Short% of Shares Outstanding of 7153005 and a Short% of Float of 7.13.
Dividends & Splits
According to the company, the forward annual dividend rate for CC is 1.00, from 1.0 in the trailing year. Against a Trailing Annual Dividend Yield of 0.058788948The stock’s 5-year Average Dividend Yield is 4.12.
